Mycobacterium tuberculosis: Immune evasion, latency and reactivation

Immunobiology

Volumn 217, Issue 3, 2012, Pages 363-374

  Gupta, Antima ^a   Kaul, Akshay ^a   Tsolaki, Anthony G ^b   Kishore, Uday ^b   Bhakta, Sanjib ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Immune evasion; Immune response; Latency; Mycobacterium tuberculosis; Reactivation

Indexed keywords

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; B LYMPHOCYTE; BACTERIAL LATENCY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; COMPLEMENT SYSTEM; DISEASE ACTIVITY; DISEASE COURSE; DISEASE TRANSMISSION; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; INNATE IMMUNITY; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENICITY; PHAGOCYTOSIS; POSTPRIMARY TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; T LYMPHOCYTE; TUBERCULOSIS;

ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENT MEMBRANE ATTACK COMPLEX; GRANULOMA; HUMANS; IMMUNE EVASION; KILLER CELLS, NATURAL; LYSOSOMES; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; PHAGOSOMES; REACTIVE NITROGEN SPECIES; TUBERCULOSIS;

EID: 84856410386     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.07.008     Document Type: Review

References (96)

1. Abbas A.K., Lichtman A.H. Basic Immunology: Functions and Disorders of the Immune System 2006, Elsevier Saunders, Philadelphia PA, 19103-2899. 2 ed.
2. Appelmelk B.J., den Dunnen J., Driessen N.N., Ummels R., Pak M., Nigou J., Larrouy-Maumus G., Gurcha S.S., Movahedzadeh F., Geurtsen J., Brown E.J., Eysink Smeets M.M., Besra G.S., Willemsen P.T.J., Lowary T.L., Van Kooyk Y., Maaskant J.J., Stoker N.G., Van Der Ley P., Puzo G., Vandenbroucke-Grauls C.M.J.E., Wieland C.W., Van Der Poll T., Geijtenbeek T.B.H., Van Der Sar A.M., Bitter W. The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell Microbiol. 2008, 10:930.
3. Baena A., Porcelli S.A. Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. Tissue Antigens 2009, 74:189.
4. Beharka A.A., Gaynor C.D., Kang B.K., Voelker D.R., McCormack F.X., Schlesinger L.S. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J. Immunol. 2002, 169:3565.
5. Bermudez L.E., Goodman J. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect Immun. 1996, 64:1400.
6. Biketov S., Potapov V., Ganina E., Downing K., Kana B.D., Kaprelyants A. The role of resuscitation promoting factors in pathogenesis and reactivation of Mycobacterium tuberculosis during intra-peritoneal infection in mice. BMC Infect Dis. 2007, 7:146.
7. Boom W.H., Canaday D.H., Fulton S.A., Gehring A.J., Rojas R.E., Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb). 2003, 83:98.
8. Botha T., Ryffel B. Reactivation of latent tuberculosis infection in TNF-deficient mice. J. Immunol. 2003, 171:3110.
9. Bouley D.M., Ghori N., Mercer K.L., Falkow S., Ramakrishnan L. Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas. Infect. Immun. 2001, 69:7820.
10. Bryk R., Lima C.D., Erdjument-Bromage H., Tempst P., Nathan C. Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein. Science 2002, 295:1073.
11. Canaday D.H., Wilkinson R.J., Li Q., Harding C.V., Silver R.F., Boom W.H. CD4+ and CD8+ Tcells kill intracellular M. tuberculosis by a perforin and FAS/FASL independent mechanism. J. Immunol. 2001, 167:2734.
12. Carroll M.V., Lack N., Sim E., Krarup A., Sim R.B. Multiple routes of complement activation by Mycobacterium bovis BCG. Mol. Immunol. 2009, 46:3367.
13. Carroll M.V., Sim R.B., Bigi F., Jäkel A., Antrobus R., Mitchell D.A. Identification of four novel DC-SIGN ligands on Mycobacterium bovis BCG. Protein Cell. 2010, 1(9):859.
14. Carsillo M., Kutala V.K., Puschel K., Blanco J., Kuppusamy P., Niewiesk S. Nitric oxide production and nitric oxide synthase type 2 expression by cotton rat (Sigmodon hispidus) macrophages reflect the same pattern as human macrophages. Dev. Comp. Immunol. 2009, 33:718.
15. Caruso A.M., Serbina N., Klein E., Triebold K., Bloom B.R., Flynn J.L. Mice deficient in CD4T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J. Immunol. 1999, 162:5407.
16. Chambers M.A., Gavier-Widen D., Hewinson R.G. Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge. FEMS Immunol. Med. Microbiol. 2004, 93.
17. Chan J., Fan X.D., Hunter S.W., Brennan P.J., Bloom B.R. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect. Immun. 1991, 59:1755.
18. Chan J., Flynn J. The immunological aspects of latency in tuberculosis. Clin. Immunol. 2004, 110:2.
19. Chang S.T., Linderman J.J., Kirschner D.E. Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:4530.
20. Chen C.Y., Huang D., Wang R.C., Shen L., Zeng G., Yao S., Shen Y., Halliday L., Fortman J., McAllister M., Estep J., Hunt R., Vasconcelos D., Du G., Porcelli S.A., Larsen M.H., Jacobs W.R., Haynes B.F., Letvin N.L., Chen Z.W. A critical role for CD8T cells in a nonhuman primate model of tuberculosis. PLoS Pathog. 2009, 5:e1000392.
21. Cole F.S., Matthews W.J., Rossing T.H., Gash D.J., Lichtenberg N.A., Pennington J.E. Complement biosynthesis by human bronchoalveolar macrophages. Clin. Immunol. Immunopathol. 1983, 27:153.
22. Diedrich C.R., Mattila J.T., Klein E., Janssen C., Phuah J., Sturgeon T.J., Montelaro R.C., Lin P.L., Flynn J.L. Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load. PLoS One 2010, 5:e9611.
23. Eruslanov E.B., Lyadova I.V., Kondratieva T.K., Majorov K.B., Scheglov I.V., Orlova M.O., Apt A.S. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect. Immun. 2005, 73:1744.
24. Fenton M.J., Riley L.W., Schlesinger L.S. Receptor-Mediated Recognition of Mycobacterium tuberculosis by Host Cells 2005, American Society for Microbiology, Washington, DC 20036-2904, USA.
25. Ferguson J.S., Martin J.L., Azad A.K., McCarthy T.R., Kang P.B., Voelker D.R., Crouch E.C., Schlesinger L.S. Surfactant protein D increases fusion of Mycobacterium tuberculosis-containing phagosomes with lysosomes in human macrophages. Infect. Immun. 2006, 74:7005.
26. Ferguson J.S., Weis J.J., Martin J.L., Schlesinger L.S. Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect. Immun. 2004, 72:2564.
27. Flynn J.L., Chan J. Tuberculosis: latency and reactivation. Infect. Immun. 2001, 69:4195.
28. Flynn J.L., Chan J. Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr. Opin. Immunol. 2003, 15:450.
29. Flynn J.L., Chan J. What's good for the host is good for the bug. Trends Microbiol. 2005, 13:98.
30. Fratti R.A., Backer J.M., Gruenberg J., Corvera S., Deretic V. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J. Cell Biol. 2001, 154:631.
31. Fratti R.A., Chua J., Vergne I., Deretic V. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:5437.
32. Glatman-Freedman A. The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy. Tuberculosis 2006, 86(3):191.
33. Gomez J.E., McKinney J.D. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb.) 2004, 84:29.
34. Hett E.C., Rubin E.J. Bacterial growth and cell division: a mycobacterial perspective. Microbiol. Mol. Biol. Rev. 2008, 72:126.
35. Hmama Z., Gabathuler R., Jefferies W.A., de Jong G., Reiner N.E. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J. Immunol. 1998, 161:4882.
36. Kang P.B., Azad A.K., Torrelles J.B., Kaufman T.M., Beharka A., Tibesar E., DesJardin L.E., Schlesinger L.S. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J. Exp. Med. 2005, 202:987.
37. Kaufmann S.H. How can immunology contribute to the control of tuberculosis?. Nat. Rev. Immunol 2001, 1:20.
38. Kaufmann S.H.E., Flynn J.L. CD8T Cells in Tuberculosis 2005, American Society for Microbiology, USA, Washington, DC, 20036-2904.
39. King P.T., Hutchinson P.E., Johnson P.D., Holmes P.W., Freezer N.J., Holdsworth S.R. Adaptive immunity to nontypeable Haemophilus influenzae. Am. J. Respir. Crit. Care Med. 2003, 167:587.
40. H17 cells. Nature 2007, 448:484.
41. Kumararatne D.S. Tuberculosis and immunodeficiency - of mice and men. Clin. Exp. Immunol. 1997, 107:11.
42. Kusner D.J., Barton J.A. ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion. J. Immunol. 2001, 167:3308.
43. Leistikow R.L., Morton R.A., Bartek I.L., Frimpong I., Wagner K., Voskuil M.I. The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J. Bacteriol. 2010, 192:1662.
44. H17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006, 203:2271.
45. Lin P.L., Flynn J.L. Understanding latent tuberculosis: a moving target. J. Immunol. 2010, 185:15.
46. Malaguarnera L., Musumeci S. The immune response to Plasmodium falciparum malaria. Lancet Infect. Dis. 2002, 2:472.
47. Malik Z.A., Denning G.M., Kusner D.J. Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. J. Exp. Med. 2000, 191:287.
48. Malik Z.A., Iyer S.S., Kusner D.J. Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages. J. Immunol. 2001, 166:3392.
49. 2+ signaling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase. J. Immunol. 2003, 170:2811.
50. Marin N.D., Paris S.C., Velez V.M., Rojas C.A., Rojas M., Garcia L.F. Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis (Edinb.) 2010, 90:252.
51. Mendelson M., Hanekom W., Kaplan G. Dendritic Cells in Host Immunity to Mycobacterium tuberculosis 2005, American Society for Microbiology, USA, Washington, DC 20036-2904.
52. Moreno C., Mehlert A., Lamb J. The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clin. Exp. Immunol. 1988, 74:206.
53. Newport M.J., Huxley C.M., Huston S., Hawrylowicz C.M., Oostra B.A., Williamson R., Levin M. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 1996, 335:1941.
54. Noss E.H., Harding C.V., Boom W.H. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell Immunol. 2000, 201:63.
55. Noss E.H., Pai R.K., Sellati T.J., Radolf J.D., Belisle J., Golenbock D.T., Boom W.H., Harding C.V. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 2001, 167:910.
56. Pai R.K., Convery M., Hamilton T.A., Boom W.H., Harding C.V. Inhibition of IFN-(-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J. Immunol. 2003, 171:175.
57. Pasula R., Downing J.F., Wright J.R., Kachel D.L., Davis T.E., Martin W.J. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 1997, 17:209.
58. Pedrosa J., Saunders B.M., Appelberg R., Orme I.M., Silva M.T., Cooper A.M. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect. Immun. 2000, 68:577.
59. Pethe K., Alonso S., Blet F., Delogu G., Brennan M.J., Locht C., Menozzi F.D. The heparine-binding haemaglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 2001, 412:190.
60. Ramos-Kichik V., Mondragon-Flores R., Mondragon-Castelan M., Gonzalez-Pozos S., Muniz-Hernandez S., Rojas-Espinosa O., Chacon-Salinas R., Estrada-Parra S., Estrada-Garcia I. Neutrophil extracellular traps are induced by Mycobacterium tuberculosis. Tuberculosis (Edinb.) 2009, 89:29.
61. Randhawa P.S. Lymphocyte subsets in granulomas of human tuberculosis: an in situ immunofluorescence study using monoclonal antibodies. Pathology 1990, 22:153.
62. Rich E.A., Torres M., Sada E., Finegan C.K., Hamilton B.D., Toossi Z. Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tuber. Lung Dis. 1997, 78:247.
63. Rock K.L., Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 2005, 207:166.
64. Russell-Goldman E., Xu J., Wang X., Chan J., Tufariello J.M. A Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity phenotypes. Infect. Immun. 2008, 76:4269.
65. Russell D.G. Mycobacterium tuberculosis: The Indigestible Microbe 2005, American Society for Microbiology, USA, Washington, DC 20036-2904.
66. Russell D.G., Vanderven B.C., Glennie S., Mwandumba H., Heyderman R.S. The macrophage marches on its phagosome: dynamic assays of phagosome function. Nat. Rev. Immunol. 2009, 9:594.
67. Sawant K.V., McMurray D.N. Guinea pig neutrophils infected with Mycobacterium tuberculosis produce cytokines which activate alveolar macrophages in noncontact cultures. Infect. Immun. 2007, 75:1870.
68. Schlesinger L.S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 1993, 150:2920.
69. Schneider B.E., Korbel D., Hagens K., Koch M., Raupach B., Enders J., Kaufmann S.H., Mittrücker H.W., Schaible U.E. A role for IL-18 in protective immunity against Mycobacterium tuberculosis. Eur. J. Immunol. 2010, 40:396.
70. Schuck S.D., Mueller H., Kunitz F., Neher A., Hoffmann H., Franken K.L., Repsilber D., Ottenhoff T.H., Kaufmann S.H., Jacobsen M. Identification of T-cell antigens specific for latent Mycobacterium tuberculosis infection. PLoS One 2009, 4:e5590.
71. Schuller S., Neefjes J., Ottenhoff T., Thole J., Young D. Coronin is involved in uptake of Mycobacterium bovis BCG in human macrophages but not in phagosome maintenance. Cell Microbiol. 2001, 3:785.
72. Sendide K., Deghmane A.E., Reyrat J.M., Talal A., Hmama Z. Mycobacterium bovis BCG urease attenuates major histocompatibility complex Class II trafficking to the macrophage cell surface. Infect. Immun. 2004, 72:4200.
73. Sester M., Giehl C., Sester U., Meyerhans A. Management of tuberculosis in HIV infection: where T-cells matter. Eur. Respir. J. 2010, 35:475.
74. Shen Y., Shen L., Sehgal P., Huang D., Qiu L., Du G., Letvin N.L., Chen Z.W. Clinical latency and reactivation of AIDS-related mycobacterial infections. J. Virol. 2004, 78:14023.
75. Sierra V.G. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion. Tuberculosis (Edinb.) 2006, 86:169.
76. St.John G., Brot N., Ruan J., Erdjument-Bromage H., Tempst P., Weissbach H., Nathan C. Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:9901.
77. Stokes R.W., Norris-Jones R., Brooks D.E., Beveridge T.J., Doxsee D., Thorson L.M. The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages. Infect. Immun. 2004, 72:5676.
78. Strunk R.C., Eidlen D.M., Mason R.J. Pulmonary alveolar type II epithelial cells synthesise and secrete proteins of the classical and alternative complement pathways. J. Clin. Invest. 1988, 81:1419.
79. Torrado E., Cooper A.M. IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev. 2010, 21:455.
80. Tufariello J.M., Chan J., Flynn J.L. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect. Dis. 2003, 3:578.
81. Vankayalapati R., Barnes P.F. Innate and adaptive immune responses to human Mycobacterium tuberculosis infection. Tuberculosis (Edinb.) 2009, 89(Suppl 1):S77.
82. Vergne I., Chua J., Deretic V. Mycobacterium tuberculosis phagosome maturation arrest: selective targeting of PI3P-dependent membrane trafficking. Traffic 2003, 4:600.
83. 2+/calmodulin-PI3K hVPS34 cascade. J. Exp. Med. 2003, 198:653.
84. Vergne I., Fratti R.A., Hill P.J., Chua J., Belisle J., Deretic V. Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion. Mol. Biol. Cell. 2004, 15:751.
85. Vieira O.V., Botelho R.J., Grinstein S. Phagosome maturation: aging gracefully. Biochem. J. 2002, 366:689.
86. Wadee A.A., Kuschke R.H., Dooms T.G. The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants. Clin. Exp. Immunol. 1995, 100:434.
87. Welin A., Winberg M.E., Abdalla H., Sarndahl E., Rasmusson B., Stendahl O., Lerm M. Incorporation of Mycobacterium tuberculosis lipoarabinomannan into macrophage membrane rafts is a prerequisite for the phagosomal maturation block. Infect. Immun. 2008, 76:2882.
88. WHO. 2010. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response, 71 pp.
89. Williams A., Reljic R., Naylor I., Clark S.O., Falero-Diaz G., Singh M., Challacombe S., Marsh P.D., Ivanyi J. Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology 2004, 111:328.
90. Wojciechowski W., DeSanctis J., Skamene E., Radzioch D. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guerin involves class II transactivator and depends on the Nramp1 gene. J. Immunol. 1999, 163:2688.
91. Wolf A.J., Desvignes L., Linas B., Banaiee N., Tamura T., Takatsu K., Ernst J.D. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 2008, 205:105.
92. Yang C.S., Yuk J.M., Jo E.K. The role of nitric oxide in mycobacterial infections. Immune Netw. 2009, 9:46.
93. Zenewicz L.A., Shen H. Innate and adaptive immune responses to Listeria monocytogenes: a short overview. Microbes Infect. 2007, 9:1208.
94. Zhang M., Lin Y., Iyer D.V., Gong J., Abrams J.S., Barnes P.F. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 1995, 63:3231.
95. Zimmerli S., Majeed M., Gustavsson M., Stendahl O., Sanan D.A., Ernst J.D. Phagosome-lysosome fusion is a calcium-independent event in macrophages. J. Cell Biol. 1996, 132:49.
96. Zvi A., Ariel N., Fulkerson J., Sadoff J.C., Shafferman A. Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses. BMC Med. Genomics 2008, 1:18.